Advertisement

Topics

Celldex’ admission of defeat sends shares spiraling down

10:51 EDT 17 Apr 2018 | thePharmaLetter

Shares in US biotech Celldex Therapeutics closed 65% down on Monday at $0.76 after the company announced…

Original Article: Celldex’ admission of defeat sends shares spiraling down

NEXT ARTICLE

More From BioPortfolio on "Celldex’ admission of defeat sends shares spiraling down"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...